Re-inventing tumor targeting

Best-in-class, TSL-based tumor targeting.

Explore the science behind Thermosome’s tumor targeting

Setting a new standard for the treatment of locally advanced soft tissue sarcoma.

Explore Thermosome’s pipeline

Experienced team of biotech entrepreneurs.

Get to know Thermosome’s team

Thermosome is a drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a new tumor targeting concept, which allows for increased local drug concentrations to achieve improved clinical treatment efficacy.

Latest news

Thermosome Establishes High-Profile Clinical Advisory Board

Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment

more news

Upcoming event

23rd Annual Biotech in Europe Forum

September 20-21, 2023
Basel, Switzerland

more Events